Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 13
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 601 | L AIR LIQUIDE SOCIETE ANONYME POUR L ETUDE ET L EXPLOITATION DES PROCEDES GEORGES CLAUDE | 26 | 00% | 15 | 11 | 2022–2026 |
| 602 | NUTRICIA | 26 | 00% | 0 | 26 | 2022–2026 |
| 603 | RESONAC | 26 | 311.5% | 1 | 22 | 2022–2026 |
| 604 | SARTORIUS STEDIM BIOTECH | 26 | 519.2% | 0 | 21 | 2021–2026 |
| 605 | SONY | 26 | 1038.5% | 2 | 14 | 2018–2026 |
| 606 | SPREADTRUM COMMUNICATIONS SHANGHAI | 26 | 1246.2% | 3 | 11 | 2022–2026 |
| 607 | TSUDAKOMA KOGYO | 26 | 27.7% | 1 | 23 | 2021–2025 |
| 608 | UMICORE | 26 | 27.7% | 1 | 23 | 2022–2026 |
| 609 | VICTAULIC | 26 | 623.1% | 1 | 19 | 2021–2026 |
| 610 | ZF FRIEDRICHSHAFEN | 26 | 311.5% | 1 | 22 | 2022–2026 |
| 611 | ABLYNX | 25 | 00% | 2 | 23 | 2022–2026 |
| 612 | ATOP | 25 | 00% | 0 | 25 | 2022–2026 |
| 613 | CONTINENTAL AUTOMOTIVE TECHNOLOGIES | 25 | 936% | 0 | 16 | 2021–2025 |
| 614 | DYNE THERAPEUTICS | 25 | 00% | 0 | 25 | 2022–2025 |
| 615 | EDWARDS LIFESCIENCES | 25 | 416% | 0 | 21 | 2019–2025 |
| 616 | ENTEGRIS | 25 | 00% | 0 | 25 | 2023–2026 |
| 617 | EXO IMAGING | 25 | 14% | 6 | 18 | 2019–2026 |
| 618 | GATES | 25 | 312% | 0 | 22 | 2022–2026 |
| 619 | IHI | 25 | 14% | 3 | 21 | 2022–2026 |
| 620 | JIANGSU FAVORED NANOTECHNOLOGY | 25 | 1144% | 0 | 14 | 2022–2025 |
| 621 | KUREHA | 25 | 312% | 3 | 19 | 2022–2026 |
| 622 | LUNG BIOTECHNOLOGY PBC | 25 | 00% | 0 | 25 | 2022–2025 |
| 623 | MULTIMATIC | 25 | 312% | 0 | 22 | 2022–2026 |
| 624 | NSK | 25 | 1144% | 0 | 14 | 2021–2025 |
| 625 | NUTRITION BIOSCIENCES USA 1 | 25 | 00% | 3 | 22 | 2022–2026 |
| 626 | OP SOLUTIONS | 25 | 28% | 0 | 23 | 2021–2026 |
| 627 | PROTERIAL | 25 | 14% | 0 | 24 | 2022–2026 |
| 628 | RECKITT BENCKISER HEALTH | 25 | 14% | 0 | 24 | 2022–2026 |
| 629 | RHODIA OPERATIONS | 25 | 520% | 4 | 16 | 2022–2025 |
| 630 | SAGE THERAPEUTICS | 25 | 28% | 7 | 16 | 2021–2025 |
| 631 | SHANGHAI DIANBA NEW ENERGY TECHNOLOGY | 25 | 832% | 0 | 17 | 2022–2025 |
| 632 | SOFTBANK GROUP | 25 | 00% | 0 | 25 | 2025–2025 |
| 633 | VERSALIS | 25 | 14% | 0 | 24 | 2022–2026 |
| 634 | VOITH PATENT | 25 | 14% | 0 | 24 | 2021–2026 |
| 635 | WESTINGHOUSE ELECTRIC | 25 | 14% | 0 | 24 | 2022–2026 |
| 636 | WITTUR HOLDING | 25 | 28% | 1 | 22 | 2022–2025 |
| 637 | ZEBRA TECHNOLOGIES | 25 | 312% | 0 | 22 | 2022–2026 |
| 638 | ZHUHAI PANTUM ELECTRONICS | 25 | 14% | 0 | 24 | 2022–2025 |
| 639 | AAK PUBL | 24 | 00% | 0 | 24 | 2022–2026 |
| 640 | AKZO NOBEL COATINGS INTERNATIONAL | 24 | 937.5% | 0 | 15 | 2022–2026 |
| 641 | ATOTECH DEUTSCHLAND KG | 24 | 312.5% | 4 | 17 | 2022–2025 |
| 642 | BOSTIK | 24 | 28.3% | 5 | 17 | 2022–2026 |
| 643 | BRASKEM | 24 | 312.5% | 5 | 16 | 2022–2026 |
| 644 | BROTHER KOGYO | 24 | 00% | 0 | 24 | 2022–2026 |
| 645 | BSH HAUSGERAETE | 24 | 00% | 0 | 24 | 2022–2024 |
| 646 | CHANGCHUN JETTY AUTOMOTIVE TECHNOLOGY | 24 | 520.8% | 0 | 19 | 2023–2024 |
| 647 | CRODA INTERNATIONAL | 24 | 416.7% | 1 | 19 | 2022–2025 |
| 648 | DANFOSS TIANJIN | 24 | 28.3% | 0 | 22 | 2022–2025 |
| 649 | EMD MILLIPORE | 24 | 312.5% | 1 | 20 | 2022–2026 |
| 650 | EXELIXIS | 24 | 14.2% | 4 | 19 | 2021–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →